Introduction Chronic constipation is a prevalent condition characterized by infrequent bowel movements (fewer than three per week), difficu…
Introduction Gastroesophageal reflux disease (GERD) in children requires an individualized treatment approach that balances effectiveness and cost…
Introduction Nonalcoholic fatty liver disease (NAFLD) has become a rising concern, often called a “sleeper epidemic.” Affecting roughly 1 in 4 pati…
Bariatric surgery has become increasingly common as an effective solution for weight loss, diabetes control, and cardiovascular risk reduction. Recog…
Resmetirom: A New Treatment for NASH/MASH Resmetirom, marketed as Rezdiffra is set to become the first medication approved for nonalcoholic steat…
Proton pump inhibitors (PPIs) remain the cornerstone for managing gastroesophageal reflux disease (GERD), see " figure 1. Diagnosis of GERD &quo…
Introduction As a clinical pharmacist, you should optimize the use of proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RA) in patients …